Duality Advisers »

Halozyme Therapeutics shares owned by Duality Advisers

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Duality Advisers from 13F filings

Historical chart of Duality Advisers investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Duality Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Duality Advisers

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.0M 53k 36.96
2023-09-30 $1.5M 40k 38.20
2023-06-30 $555k 15k 36.07
2023-03-31 $2.6M 69k 38.19
2022-12-31 $2.1M 38k 56.90
2022-03-31 $483k 12k 39.87
2021-09-30 $3.7M 91k 40.68
2021-03-31 $830k 20k 41.69
2020-09-30 $1.1M 41k 26.28
2020-06-30 $887k 33k 26.82
2019-12-31 $396k 22k 17.73